Articles tagged "Living donor"

2021 American Transplant Congress
The Experience of 1000 Hand Assisted Laparoscopic Donor Nephrectomy for Living Donor Kidney Transplantation
T. Hiramitsu¹, T. Tomosugi², K. Futamura², M. Okada², N. Goto², T. Ichimori², S. Narumi², Y. Watarai²
¹Nagoya Daini Red Cross Hospital, Myokencho Showaku, Japan, ²Nagoya Daini Red Cross Hospital, Nagoya, Japan
*Purpose: Due to the profound organ shortage, living donor kidney transplantation becomes more necessary. Hand assisted laparoscopic donor nephrectomy (HALDN) is widely performed to lessen…
2021 American Transplant Congress
Impact of Pediatric Living Donor Liver Transplant Center Volume on Waiting List and Post-Transplant Outcomes
D. Yoeli, R. A. Choudhury, H. B. Moore, T. L. Nydam, M. E. Wachs, E. A. Pomfret, M. A. Adams
Transplant Surgery, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
*Purpose: The aim of this study was to compare pediatric liver transplant (pLT) waiting list and post-transplant outcomes by center pediatric living donor liver transplant…
2021 American Transplant Congress
Paired Exchanges in LDLT- A Good Option for Patients with Incompatible Donors
A. Humar, C. Hughes, G. Mazariegos, S. Kyle, A. Gallatin, K. Emmett, A. Tevar, M. Molinari, A. Ganoza, V. Gunabushanam, S. Ganesh
University of Pittsburgh, Pittsburgh, PA
*Purpose: In the US, paired exchanges are common for LD kidney transplant but not for LDLT. We present our series of paired exchanges for LDLT,…
2021 American Transplant Congress
The Risk of Post-donation Kidney Function Impairment for Prospective Living Kidney Donors with Persistent Isolated Microscopic Hematuria
J. v. Weijden¹, M. van Londen¹, I. M. Nolte², M. H. De Borst¹, S. P. Berger¹
¹Nephrology, University Medical Center Groningen, Groningen, Netherlands, ²Epidemiology, University Medical Center Groningen, Groningen, Netherlands
*Purpose: According to current guidelines, a kidney biopsy is indicated in prospective living kidney donors who present with persistent isolated microscopic hematuria (PIMH) during evaluation,…
2021 American Transplant Congress
Patient Survival After Living Donor Kidney Donation
M. G. Naik, K. Sakurayama, K. Budde, F. Halleck
Medical Department, Division of Nephrology and Internal Intensive Care Medicine, Charité, Berlin, Germany
*Purpose: Living donor kidney transplantation [LDKT] is associated with best patient survival and life quality among kidney replacement therapies in case of chronic kidney disease.…
2021 American Transplant Congress
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
M. Anand, S. Barhorst, S. Bumb, B. Abu Jawdeh, T. Kaur, A. Govil
University of Cincinnati, Cincinnati, OH
*Purpose: Medically complex donors are increasingly being assessed for donation. Due to concern for donor safety, there is a wide variation amongst transplant providers in…
2021 American Transplant Congress
Impact of COVID-19 Crisis on Disparities in Living Kidney Donation in the US
J. Wainright, S. Booker, J. Foutz, A. Henderson, R. Goff, L. Cartwright, D. Klassen
Research, UNOS, Richmond, VA
*Purpose: The COVID-19 pandemic resulted in a dramatic decrease in living kidney donation (LKD) in the U.S. This study investigated the effect of the COVID…
2021 American Transplant Congress
Impact of Advanced Renal Dysfunction on Post-Transplant Outcomes After Living Donor Liver Transplantation in the United States
T. Bittermann¹, N. Kaur², P. L. Abt¹, K. M. Olthoff¹, J. K. Heimbach³, J. Emamaullee²
¹University of Pennsylvania, Philadelphia, PA, ²University of Southern California, Los Angeles, CA, ³Mayo Clinic College of Medicine, Rochester, MN
*Purpose: Survival after living donor liver transplantation (LDLT) in the U.S. is excellent. However, the significance of pre-transplant kidney disease on outcomes after LDLT is…
2021 American Transplant Congress
Living Donor Kidney Transplantation Racial Disparities Persist Independent of Social Vulnerability
A. C. Killian¹, M. C. McLeod¹, B. Shelton¹, R. D. Reed¹, P. MacLennan¹, H. Qu¹, B. J. Orandi¹, V. Kumar¹, D. Sawinski², R. M. Cannon¹, D. J. Anderson¹, M. J. Hanaway¹, J. E. Locke¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Living donor kidney transplantation (LDKT) confers a significant survival benefit over deceased donor transplantation. Racial disparities in access to LDKT are well recognized, yet…
2021 American Transplant Congress
Impact of Rituximab Induction Therapy on Donor-specific Anti-HLA Antibodies in Abo-compatible Kidney Transplant Recipients
T. Yagisawa¹, T. Kanzawa¹, K. Unagami², M. Furusawa¹, M. Inui¹, H. Ishida², K. Tanabe¹
¹Department of Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Department of Organ Transplant Medicine, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: Development of de novo donor-specific anti-HLA antibodies (dnDSA) after kidney transplantation remains strongly associated with antibody-mediated rejection (AMR), which leads to poor graft outcome.…